Elios Financial Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$363K Sell
465
-33
-7% -$25.6K 0.16% 97
2025
Q1
$411K Buy
498
+8
+2% +$6.66K 0.2% 84
2024
Q4
$378K Buy
490
+1
+0.2% +$828 0.18% 89
2024
Q3
$433K Buy
+489
New +$440K 0.2% 84

Other funds holding LLY

Elios Financial Group's LLY Position: Q2 2025 in Review

Elios Financial Group reduced its Eli Lilly (LLY) stake by 6.6% in Q2 2025, selling an estimated $25.6K and leaving 465 shares worth $363K. The position accounts for 0.16% of the portfolio, ranked #97.

Elios Financial Group first reported a position in LLY in Q3 2024 and has held it in 4 quarters since. The position peaked at $433K in Q3 2024. 3,914 funds tracked by Wall St. Rank hold LLY as of Q2 2025.

  • Elios Financial Group held 465 shares of Eli Lilly worth $363K as of Q2 2025.
  • Elios Financial Group sold 33 Eli Lilly shares in Q2 2025, an estimated $25.6K.
  • Eli Lilly made up 0.16% of Elios Financial Group's portfolio in Q2 2025, its #97 holding.
  • Elios Financial Group first reported a position in Eli Lilly in Q3 2024 and has held it in 4 quarters since.
  • Elios Financial Group's Eli Lilly position peaked at $433K in Q3 2024.
  • 3,914 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2025.

Based on Elios Financial Group's 13F filing for Q2 2025, filed 13 Aug 2025.